Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Total Non-Current Liabilities (2023 - 2025)

Cannabis Bioscience International Holdings' Total Non-Current Liabilities history spans 3 years, with the latest figure at $249500.0 for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 23.69% year-over-year to $249500.0; the TTM value through Nov 2025 reached $249500.0, down 23.69%, while the annual FY2025 figure was $249500.0, 1.87% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $249500.0 at Cannabis Bioscience International Holdings, roughly flat from $249500.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $326937.0 in Q4 2024 and bottomed at $249500.0 in Q2 2023.
  • The 3-year median for Total Non-Current Liabilities is $251883.5 (2023), against an average of $265154.2.
  • The largest annual shift saw Total Non-Current Liabilities increased 15.35% in 2024 before it fell 23.69% in 2025.
  • A 3-year view of Total Non-Current Liabilities shows it stood at $283420.0 in 2023, then rose by 15.35% to $326937.0 in 2024, then dropped by 23.69% to $249500.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Total Non-Current Liabilities are $249500.0 (Q4 2025), $249500.0 (Q3 2025), and $249500.0 (Q2 2025).